Tag Archives: high-risk patients

Choosing the right treatment for patients with both diabetes and heart disease can feel like walking a tightrope. With evolving evidence, the role of incretin therapy in cardiovascular disease management is now at the center of clinical decision-making. Recent cardiovascular outcomes trials have shifted how clinicians think about therapy selection, …

Why do people with diabetes face such frequent infections—and what can clinicians do to reduce the risk? With elevated blood glucose impairing immune function and circulation, patients with diabetes are more vulnerable to infections that can escalate quickly, from respiratory issues to stubborn foot ulcers. Understanding this connection is critical …